SCHEMBL7101534

SCHEMBL7101534

N#Cc1ccc(-c2ccccc2CC(=O)Nc2cccc(C#N)c2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.63
ALDH1A1 P00352 4/20 0.56
DUSP3 P51452 1/20 0.56
KMT2A Q03164 5/20 0.54
MAPT P10636 4/20 0.54
MEN1 O00255 3/20 0.54
MAPK1 P28482 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HSD17B10 Q99714 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
TSHR P16473 2/20 0.49
ANO1 Q5XXA6 1/20 0.48
HPGD P15428 1/20 0.47
KDR P35968 1/20 0.47
HTT P42858 2/20 0.47
ACHE P22303 1/20 0.47
BACE1 P56817 1/20 0.47
GRM4 Q14833 1/20 0.46
POLB P06746 1/20 0.46
PTK2B Q14289 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163952 0.94 LMNA (0.57) LMNAALDH1A1DUSP3KMT2AMAPT
SCHEMBL6165957 0.91 LMNA (0.64) LMNAALDH1A1DUSP3KMT2AMAPT
SCHEMBL6167046 0.89 RORC (0.49) LMNAALDH1A1KMT2AMAPTMEN1
SCHEMBL7108448 0.88 LMNA (0.53) LMNAALDH1A1DUSP3KMT2AMAPT
SCHEMBL29767752 0.78 LMNA (1.00) LMNAALDH1A1DUSP3KMT2AMAPT
SCHEMBL6165775 0.78 MAPT (0.68) LMNAALDH1A1KMT2AMAPTMEN1
SCHEMBL20941585 0.77 ALDH1A1 (0.77) LMNAALDH1A1KMT2AMAPTMEN1
SCHEMBL6167998 0.76 PTGDR2 (0.55) KMT2A
SCHEMBL7106840 0.76 DRD2 (0.53) ALDH1A1HPGDGAA
SCHEMBL8639463 0.75 CYP1A2 (0.63) LMNAALDH1A1KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof F2, F12, TFPI LMNA 772/4885ALDH1A1 1388/4885DUSP3 2934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.